Mediterranean Diet Tied to Lower Risk for Prostate Cancer Progression
THURSDAY, Jan. 21, 2021 -- For men with newly diagnosed prostate cancer on active surveillance, adherence to the Mediterranean diet (MedD) is associated with a lower risk for Gleason grade group progression, according to a study published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 21, 2021 Category: Pharmaceuticals Source Type: news

Coffee Tied to Lower Risk of Prostate Cancer
Each additional daily cup of coffee was associated with a 1 percent decrease in the risk of prostate cancer. (Source: NYT Health)
Source: NYT Health - January 21, 2021 Category: Consumer Health News Authors: Nicholas Bakalar Tags: Prostate Cancer Coffee BMJ Open (Journal) Source Type: news

ORGOVYX (relugolix), the First FDA-Approved Oral Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonist for Advanced Prostate Cancer, Available at Biologics by McKesson
CARY, N.C., Jan. 21, 2021 —Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, has been selected by Myovant Sciences as a specialty pharmacy provider for ORGOVYXTM (relugolix) for the treatment of advanced prostate cancer. (Source: McKesson News)
Source: McKesson News - January 21, 2021 Category: Information Technology Source Type: news

Cancer can be precisely diagnosed using a urine test with artificial intelligence
(National Research Council of Science& Technology) The Korea Institute of Science and Technology(KIST) announced that the collaborative research team led by Dr. Kwan Hyi Lee from the Biomaterials Research Center and Professor In Gab Jeong from Asan Medical Center developed a technique for diagnosing prostate cancer from urine within only twenty minutes with almost 100% accuracy. The research team developed this technique by introducing a smart AI analysis method to an electrical-signal-based ultrasensitive biosensor. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 21, 2021 Category: International Medicine & Public Health Source Type: news

Cancer Surgery Mortality Down, but Racial Disparities Persist Cancer Surgery Mortality Down, but Racial Disparities Persist
In recent years, deaths after cancer surgery have decreased for all types of cancer except among Black patients undergoing prostate cancer surgery, but racial disparity gaps persist.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 19, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Cancer Surgery Mortality Down, but Racial Disparities Persist Cancer Surgery Mortality Down, but Racial Disparities Persist
In recent years, deaths after cancer surgery have decreased for all types of cancer except among Black patients undergoing prostate cancer surgery, but racial disparity gaps persist.Medscape Medical News (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - January 19, 2021 Category: Surgery Tags: Hematology-Oncology News Source Type: news

AI, radiomics predicts prostate cancer recurrence
A diagnostic model that incorporates artificial intelligence (AI) analysis...Read more on AuntMinnie.comRelated Reading: FDA makes history with approval of Ga-68 PSMA-11 PET Federated learning may boost AI generalizability Radiation therapy takes toll on prostate cancer patients' finances PSMA-PET reveals new salivary glands SNMMI 2020: AI analysis of PET could help classify prostate cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 19, 2021 Category: Radiology Source Type: news

Prostate cancer symptoms: How often do you experience ‘terminal dribbling’? Warning sign
PROSTATE cancer is the most common cancer in men in the UK, with over 40000 new cases diagnosed every year. One telltale sign you have prostate cancer is terminal dribbling. (Source: Daily Express - Health)
Source: Daily Express - Health - January 16, 2021 Category: Consumer Health News Source Type: news

Prostate cancer warning: Bisphenol A found on receipts could be increasing your risk
PROSTATE cancer warning: More and more cases of men being diagnosed with the deadly disease are taking place in the UK. Could a chemical in receipts be the cause of the sudden surge in recent years? (Source: Daily Express - Health)
Source: Daily Express - Health - January 16, 2021 Category: Consumer Health News Source Type: news

Can MRI-guided breast biopsy evaluate chemo response?
MRI-guided breast biopsy looks like a promising method to evaluate complete...Read more on AuntMinnie.comRelated Reading: Breast MRI shows promise for surgical planning Multiple DWI-MRI metrics can cut breast biopsy rate 3 topics shaping the future of women's imaging MRI-guided biopsy improves prostate cancer assessment MRI-guided prostate biopsies improve cancer detection (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 16, 2021 Category: Radiology Source Type: news

An unexpected, and novel, target for prostate cancer - our biological clock
(Thomas Jefferson University) Researchers find that CRY-1, a regulator of circadian rhythms, promotes tumor progression by altering DNA repair. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - January 15, 2021 Category: Biology Source Type: news

PET/CT guidance offers valuable approach to lung biopsies
One optimum way to reduce inconclusive lung biopsy results and better detect...Read more on AuntMinnie.comRelated Reading: PET/CT with Ga-68 tracer better for cancer patients Dual-phase technique improves PET/CT brain tumor imaging PET/CT could be useful for diagnosing fever SNMMI 2020: PSMA-PET/CT changes prostate cancer management PET/CT confirms breast cancer predicted by blood markers (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 13, 2021 Category: Radiology Source Type: news

What Are the Five Warning Signs of Prostate Cancer?
Title: What Are the Five Warning Signs of Prostate Cancer?Category: Diseases and ConditionsCreated: 1/13/2021 12:00:00 AMLast Editorial Review: 1/13/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - January 13, 2021 Category: Cancer & Oncology Source Type: news

Lantheus submits drug master file for imaging biomarker
Lantheus Holdings, parent company of Lantheus Medical Imaging, said that it...Read more on AuntMinnie.comRelated Reading: Point Biopharma to use Lantheus' PyL in clinical trial Lantheus divests Puerto Rico nuclear medicine businesses FDA clears Lantheus' AI bone software Sofie, Lantheus ink deal for prostate cancer imaging agent Lantheus reports mixed Q3 results (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 12, 2021 Category: Radiology Source Type: news

Higher Coffee Intake May Reduce Risk for Prostate Cancer
Pooled relative risk of 0.988 for each increment of one cup of coffee per day revealed in meta - analysis of cohort studies (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - January 12, 2021 Category: Cancer & Oncology Tags: Internal Medicine, Oncology, Urology, Journal, Source Type: news

ARTMS, Telix produce PSMA-11 in cyclotron
ARTMS and Telix Pharmaceuticals this week announced a milestone in their relationship...Read more on AuntMinnie.comRelated Reading: ARTMS Tc-99m gets green light from Health Canada Telix files NDA for prostate cancer PET imaging agent RefleXion, Telix partner on high-risk cancer treatments ARTMS raises $19M in funding round Companies partner on gallium-68 imaging ANMI inks deal for SPECT radiopharmaceutical (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 12, 2021 Category: Radiology Source Type: news

Higher Coffee Intake May Reduce Risk for Prostate Cancer
TUESDAY, Jan. 12, 2021 -- Increased coffee consumption is associated with a reduced risk for prostate cancer, according to a review and meta-analysis published online Jan. 11 in BMJ Open. Xiaonan Chen, from Shengjing Hospital of China Medical... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 12, 2021 Category: Pharmaceuticals Source Type: news

Coffee Might Help Ward Off Prostate Cancer
TUESDAY, JAN. 12, 2021 -- A cup of java may not be a bad idea for men's health: Drinking lots of coffee may reduce their risk of prostate cancer, researchers report. The investigators analyzed data from 16 studies conducted around the world.... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 12, 2021 Category: General Medicine Source Type: news

Coffee Might Help Ward Off Prostate Cancer
Title: Coffee Might Help Ward Off Prostate CancerCategory: Health NewsCreated: 1/12/2021 12:00:00 AMLast Editorial Review: 1/12/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - January 12, 2021 Category: Cancer & Oncology Source Type: news

Study: Coffee reduces risk for prostate cancer
Drinking several cups of coffee daily appears to lower risk for developing prostate cancer, according to an analysis published Monday by BMJ Open. (Source: Health News - UPI.com)
Source: Health News - UPI.com - January 11, 2021 Category: Consumer Health News Source Type: news

Whole-Pelvis Radiotherapy for High-Risk Prostate Cancer Whole-Pelvis Radiotherapy for High-Risk Prostate Cancer
Irradiating the whole pelvis rather than just the prostate reduces the likelihood of recurrence in men with high-risk locally advanced prostate cancer, according to a randomized controlled trial.Medscape Medical News (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - January 11, 2021 Category: Radiology Tags: Hematology-Oncology News Source Type: news

Mediterranean Diet Could Help Stop Prostate Cancer's Spread
FRIDAY, Jan. 8, 2021 -- Food as medicine: New research suggests that a healthy Mediterranean diet might lower the risk of prostate cancer progressing to a more advanced state. The relative lack of saturated fat in these diets might be a major... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 8, 2021 Category: General Medicine Source Type: news

Genes Help Explain Role of Race in Prostate Cancer Risk
Title: Genes Help Explain Role of Race in Prostate Cancer RiskCategory: Health NewsCreated: 1/7/2021 12:00:00 AMLast Editorial Review: 1/8/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - January 8, 2021 Category: Cancer & Oncology Source Type: news

Mediterranean Diet Could Help Stop Prostate Cancer's Spread
Title: Mediterranean Diet Could Help Stop Prostate Cancer's SpreadCategory: Health NewsCreated: 1/8/2021 12:00:00 AMLast Editorial Review: 1/8/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - January 8, 2021 Category: Cancer & Oncology Source Type: news

Study reveals: Men should eat walnuts to prevent prostate cancer
(Natural News) Good news, gentlemen: Eating walnuts can help stave off prostate cancer. This is according to researchers from the University of California, Davis, who found that walnuts, aside from helping to reduce excess cholesterol and increasing insulin sensitivity, are also capable of reducing the levels of a protein associated with prostate cancer. According to nutritionist Paul Davis, who... (Source: NaturalNews.com)
Source: NaturalNews.com - January 7, 2021 Category: Consumer Health News Source Type: news

MRI frequently underestimates tumor size in prostate cancer
FINDINGSA study led by researchers at theUCLA Jonsson Comprehensive Cancer Center has found that magnetic resonance imaging, or MRI, frequently underestimates the size of prostate tumors, potentially leading to undertreatment.The study authors found that such underestimation occurs most often when the MRI-measured tumor size is small and the PI-RADS score, which is used to classify lesions in prostate MRI analysis, is low.For prostate tumor treatments to be successful, both the MRI size measurement and PI-RADS score must be accurate because they allow physicians to determine precisely where tumors end and where the normal,...
Source: UCLA Newsroom: Health Sciences - January 7, 2021 Category: Universities & Medical Training Source Type: news

Genes Help Explain Role of Race in Prostate Cancer Risk
THURSDAY, Jan. 7, 2021 -- If you're a Black man, your risk of getting prostate cancer is 75% higher than it is for a white man, and it's more than twice as deadly. Now, research is helping to bring genetic risks for people of various racial and... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 7, 2021 Category: General Medicine Source Type: news

MRI frequently underestimates tumor size in prostate cancer
(University of California - Los Angeles Health Sciences) Improving imaging processes will lead to more successful treatments and help reduce morbidity in men with the disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 7, 2021 Category: International Medicine & Public Health Source Type: news

Mediterranean diet may decrease risk of prostate cancer progression
(University of Texas M. D. Anderson Cancer Center) In a study to examine a Mediterranean diet in relation to prostate cancer progression in men on active surveillance, researchers from The University of Texas MD Anderson Cancer Center found that men with localized prostate cancer who reported a baseline dietary pattern that more closely follows the key principles of a Mediterranean-style diet fared better over the course of their disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 7, 2021 Category: International Medicine & Public Health Source Type: news

Epigenetics may improve prediction of prostate cancer threat
Two research groups used different methods to discover epigenetic biomarkers that may prove helpful in improving prostate cancer prediction. (read more) (Source: Environmental Factor - NIEHS Newsletter)
Source: Environmental Factor - NIEHS Newsletter - January 6, 2021 Category: Environmental Health Source Type: news

New clues to prostate cancer
(Flinders University) Australian research has identified a new mechanism in which prostate cancer cells can 'switch' character and become resistant to therapy. These findings, just published in Cell Reports, are an important development in unravelling how an aggressive subtype of prostate cancer, neuroendocrine prostate cancer (NEPC), develops after hormonal therapies. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 5, 2021 Category: Cancer & Oncology Source Type: news

ViewRay posts mixed financial results for Q4, year
Image-guided radiation therapy vendor ViewRay reported a sharp decline in revenues...Read more on AuntMinnie.comRelated Reading: South Korean hospital hits milestone with ViewRay system ViewRay's revenue plummets in Q3 ViewRay touts MRIdian papers at ASTRO 2020 ViewRay wins Ohio MRIdian Linac contract ViewRay highlights results from prostate cancer study (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 4, 2021 Category: Radiology Source Type: news

CEO of growing Peninsula biotech steps down in wake of FDA approval, big Pfizer deal
The sudden CEO switch comes as the company preps for the launch of its prostate cancer drug, seeks FDA approval of a treatment for heavy menstrual bleeding and looks to cut deals to beef up its drug portfolio. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 4, 2021 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

Inflammation from ADT may cause fatigue in prostate cancer patients
(H. Lee Moffitt Cancer Center& Research Institute) Moffitt Cancer Center researchers are investigating whether inflammation in the body, a side effect of ADT, contributes to these symptoms in prostate cancer patients. In a new study published in the journal Cancer, they pinpoint a specific inflammation marker that is associated with increased fatigue in this group of patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 4, 2021 Category: International Medicine & Public Health Source Type: news

Largest, most diverse ever study of prostate cancer genetics brings disparities into focus
(Keck School of Medicine of USC) The largest, most diverse study of genetic variations related to prostate cancer shows evidence that genetics play some part in health disparities among different racial groups. The analysis includes 269 genetic variations that increase risk, 86 of them newly discovered by the researchers. Assessing risk based on a model incorporating these genetic factors researchers showed that men of African ancestry inherit about twice the prostate cancer risk on average compared to men of European ancestry. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - January 4, 2021 Category: Biology Source Type: news

Jimmy Tarbuck health: The comedian is fighting prostate cancer - symptoms of the disease
JIMMY TARBUCK is a veteran Liverpudlian comic, returning to our screens to tell the story of his extraordinary life. The 80-year-old is currently fighting against prostate cancer - what are the signs of the disease? (Source: Daily Express - Health)
Source: Daily Express - Health - January 3, 2021 Category: Consumer Health News Source Type: news

Risk Stratification of Prostate Cancer Through qPTEN Risk Stratification of Prostate Cancer Through qPTEN
In this study, the authors describe a quantitative approach for the risk stratification of prostate cancer patients. Could this tool help guide management decisions?Journal of the National Cancer Institute (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 1, 2021 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

With potential $4B Pfizer deal, 'upside-down' Peninsula biotech on hunt for more drugs
Myovant Sciences Ltd. will use the financial muscle generated by a potential $4.2 billion deal with drug giant Pfizer Inc. to beef up its pipeline of cancer and women's health drugs. The Pfizer compact, disclosed Monday, centers on Brisbane-based Myovant's potential blockbuster drug relugolix, which won Food and Drug Administration approval this month as the first oral hormone therapy for men with advanced prostate cancer. Myovant's stock climbed as high as $30.90 per share M onday — a new 52-week… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 28, 2020 Category: Biotechnology Authors: Ron Leuty Source Type: news

With potential $4B Pfizer deal, 'upside-down' Peninsula biotech on hunt for more drugs
Myovant Sciences Ltd. will use the financial muscle generated by a potential $4.2 billion deal with drug giant Pfizer Inc. to beef up its pipeline of cancer and women's health drugs. The Pfizer compact, disclosed Monday, centers on Brisbane-based Myovant's potential blockbuster drug relugolix, which won Food and Drug Administration approval this month as the first oral hormone therapy for men with advanced prostate cancer. Myovant's stock climbed as high as $30.90 per share M onday — a new 52-week… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - December 28, 2020 Category: American Health Authors: Ron Leuty Source Type: news

With potential $4 billion Pfizer deal, 'upside-down' Peninsula biotech on hunt for more drugs
Myovant Sciences Ltd. will use the financial muscle generated by a potential $4.2 billion deal with drug giant Pfizer Inc. to beef up its pipeline of cancer and women's health drugs. The Pfizer compact, disclosed Monday, centers on Brisbane-based Myovant's potential blockbuster drug relugolix, which won Food and Drug Administration approval this month as the first oral hormone therapy for men with advanced prostate cancer. Myovant's stock climbed as high as $30.90 per share M onday — a new 52-week… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 28, 2020 Category: Biotechnology Authors: Ron Leuty Source Type: news

With potential $4 billion Pfizer deal, 'upside-down' Peninsula biotech on hunt for more drugs
Myovant Sciences Ltd. will use the financial muscle generated by a potential $4.2 billion deal with drug giant Pfizer Inc. to beef up its pipeline of cancer and women's health drugs. The Pfizer compact, disclosed Monday, centers on Brisbane-based Myovant's potential blockbuster drug relugolix, which won Food and Drug Administration approval this month as the first oral hormone therapy for men with advanced prostate cancer. Myovant's stock climbed as high as $30.90 per share M onday — a new 52-week… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - December 28, 2020 Category: American Health Authors: Ron Leuty Source Type: news

Prostate Cancer Incidence and Survival, by Stage and Ethnicity Prostate Cancer Incidence and Survival, by Stage and Ethnicity
This report reveals that the incidence of distant-stage prostate cancer has significantly increased in recent years.Morbidity & Mortality Weekly Report (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 25, 2020 Category: Consumer Health News Tags: Public Health & Prevention Journal Article Source Type: news

Prostate cancer: Nocturia and pain when urinating are two lesser-known signs to spot
PROSTATE cancer is the most common cancer to affect British men. With early warning signs hard to come by, make sure you're aware of the lesser-known symptoms that could appear when the tumour grows larger. (Source: Daily Express - Health)
Source: Daily Express - Health - December 24, 2020 Category: Consumer Health News Source Type: news

New oral hormone drug for prostate cancer
The Food and Drug Administration has approved the use of a new oral hormone therapy drug, Relugolix, for treating advanced prostate cancer in men.Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - December 22, 2020 Category: Endocrinology Source Type: news

FDA Approves First Oral Hormone Therapy for Advanced Prostate Cancer
MONDAY, Dec. 21, 2020 -- Orgovyx (relugolix) is now approved to treat advanced prostate cancer and is the first oral hormone therapy approved for this indication, the U.S. Food and Drug Administration announced Friday. As opposed to currently... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 21, 2020 Category: Pharmaceuticals Source Type: news

Prostate cancer regulator plays role in COVID-19, providing a promising treatment lead
(Michigan Medicine - University of Michigan) By taking a lesson from prostate cancer, researchers now have a promising lead on a treatment for COVID-19. They found that, just like in prostate cancer, TMPRSS2 is regulated by the androgen receptor in the lungs. And notably, blocking the androgen receptor led to lower expression of TMPRSS2, which led to decreased coronavirus infection in mice and cellular models. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 21, 2020 Category: International Medicine & Public Health Source Type: news

Mayo Clinic Radio podcast: 12/19/20
On?the Mayo Clinic Radio?program,?Dr. Derek Lomas, a Mayo Clinic urologist, discusses?prostate cancer, including a new biopsy method. Also on the program,?Dr. Todd Miller, a Mayo Clinic cardiologist, explains how?exercise affects the heart. And?Dr. Beth Robertson, a Mayo Clinic neurologist, discusses?headaches?and treatment for?migraines. (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - December 19, 2020 Category: Databases & Libraries Source Type: news

Four years after grabbing shelved drug, Peninsula company wins FDA approval in prostate cancer
It is the second FDA-approved prostate cancer drug that CEO Lynn Seely has shepherded through clinical trials. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 18, 2020 Category: Biotechnology Authors: Ron Leuty Source Type: news

Four years after grabbing shelved drug, Peninsula company wins FDA approval in prostate cancer
It is the second FDA-approved prostate cancer drug that CEO Lynn Seely has shepherded through clinical trials. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - December 18, 2020 Category: American Health Authors: Ron Leuty Source Type: news

FDA OKs First Oral Hormone Tx for Advanced Prostate Cancer FDA OKs First Oral Hormone Tx for Advanced Prostate Cancer
Relugolix is an oral form of androgen deprivation therapyFDA Approvals (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - December 18, 2020 Category: Urology & Nephrology Tags: Hematology-Oncology News Source Type: news